HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer

Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer
M. Dorsch, F. E. G. Beaudry, A. K. Baginska +31
bioRxiv6 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
1105 HER3 inhibition sensitizes metastatic colorectal and pancreatic cancer to immunotherapy
Rui Wang, Elizabeth Bryson, Chao Wei +3
Journal for ImmunoTherapy of Cancer7 Nov 2026Peer-reviewedCC BYFull textOncologyDOAJ
KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma
y. chen, C. Haffner, B. Chellakkan Selvanesan +24
bioRxiv5 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
Research advances in amino acid metabolic reprogramming in colorectal cancer liver metastasis
WANG Ercong, YAN Junqian, JIA Xiahe +4
Zhongguo aizheng zazhi1 Sep 2026Peer-reviewedCC BY-NC-NDFull textOncologyDOAJ
Aberrant CPS1 expression is linked to metabolic alterations and metastatic phenotypes in colorectal cancer liver metastasis
Qin Xiang, Ming Yang, Xiaoyu Li +7
Scientific Reports1 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref

Cite

BibTeX

@misc{rathore2026her3,
  title = {{HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer}},
  author = {M. Rathore and C. Wei and J. Winter and R. Wang},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.30.763164},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.30.763164v1},
}

RIS

TY  - UNPB
TI  - HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
AU  - M. Rathore
AU  - C. Wei
AU  - J. Winter
AU  - R. Wang
PY  - 2026
DA  - 2026/10/30
PB  - bioRxiv
DO  - 10.64898/2026.10.30.763164
UR  - https://www.biorxiv.org/content/10.64898/2026.10.30.763164v1
ER  -

Related

Cite